SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001420720-23-000060
Filing Date
2023-10-26
Accepted
2023-10-26 08:20:58
Documents
7
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20231127xdef14a.htm DEF 14A 1341948
2 GRAPHIC tmb-20231127xdef14a_a001.jpg GRAPHIC 7363
3 GRAPHIC tmb-20231127xdef14a_a002.jpg GRAPHIC 5872
4 GRAPHIC tmb-20231127xdef14a_a009.jpg GRAPHIC 28557
5 GRAPHIC tmb-20231127xdef14a_a010.jpg GRAPHIC 28073
6 GRAPHIC tmb-20231127xdef14a_bg001.jpg GRAPHIC 234575
7 GRAPHIC tmb-20231127xdef14a_bg002.jpg GRAPHIC 153942
  Complete submission text file 0001420720-23-000060.txt   1975355
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 231347575
SIC: 2834 Pharmaceutical Preparations